The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia

Journal of Infection and Chemotherapy

Volumn 10, Issue 1, 2004, Pages 62-64

  Kataoka, Daisuke ^a   Tanaka, Yoshinori ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Aztreonam; Cefozopran; Stenotrophomonas maltophilia; lactamase

Indexed keywords

AZTREONAM; CEFOZOPRAN; CEFPIROME; CEFTAZIDIME; CLAVULANIC ACID; IMIPENEM; PENICILLINASE; THIOGLYCOLIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG POTENTIATION; GRAM NEGATIVE INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STENOTROPHOMONAS MALTOPHILIA; TREATMENT PLANNING;

EID: 1542318254     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0288-9     Document Type: Article

References (12)

1. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998;11:57-80.
2. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321-31.
3. Krueger TS, Clark EA, Nix DE. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations. Diagn Microbiol Infect Dis 2001;41:71-8.
4. Lister PD, Sanders WE, Sanders CC. Cefepime-aztreonam: a unique double β-lactam combination for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998;42:1610-9.
5. Song W, Woo HJ, Kim JS, Lee KM. In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Int J Antimicrob Agents 2003;21:8-12.
6. Nishida K, Kunugita C, Uji T, Higashitani F, Hyodo A, Unemi N, et al. In vitro and in vivo activities of Syn2190, a novel β-lactamase inhibitor. Antimicrob Agents Chemother 1999;43:1895-900.
7. Kataoka D, Fujiwara H, Kawakami T, Tanaka Y, Tanimoto A, Ikawa S, et al. The indirect pathogenicity of Stenotrophomonas maltophilia. Int J Antimicrob Agents 2003;22:601-6.
8. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000;38:40-3.
9. Coudron PE, Hanson ND, Climo MW. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases. J Clin Microbiol 2003;41:772-7.
10. Fang H, Edlund C, Hedberg M, Nord CE. New findings in beta-lactam and metronidazole resistant Bacteroidesfragilis group. Int J Antimicrob Agents 2002;19:361-70.
11. Kataoka D, Fujiwara H, Tanimoto A, Ikawa S, Tanaka Y. The differential β-lactamase activity of Stenotrophomonas maltophilia. J Hosp Infect 2003;54:246-8.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th Ed; document M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997.